Sammaan Capital Limited
The international credit rating agency S&P Global Ratings has upgraded Sammaan Capital Limited s long-term [International] credit rating to BB- with Stable Outlook.The rating upgrade reflects the continued strengthening of the Company’s credit profile following the strategic investment by International Holding Company PJSC (IHC). S&P expects an improvement in business profile, enhanced funding access, continued strong capitalization, and increase in profitability.With CRISIL having upgraded the Company s long-term rating to CRISIL AA+/Stable on April 9, 2026, CARE Ratings having upgraded the Company s long-term rating to CARE AA+; Stable on May 12, 2026, and ICRA having upgraded the Company s long-term rating to [ICRA]AA+/Stable on May 20, 2026, all the major rating agencies covering the Company have now upgraded their ratings following IHC s investment in the Company on March 31, 2026.The successive rating upgrades have already translated into improved market confidence and a meaningful reduction in the Company s incremental borrowing costs. Enhanced funding access and a lower cost of funds will strengthen the Company s competitive position, support higher disbursements and accelerate execution of its growth strategy. |SUBJECT: Credit Rating- Revision
More Stories
Bhagiradha Chemicals & Industries Limited
Bhagiradha Chemicals & Industries Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and...
HFCL Limited
HFCL Limited has informed the Exchange about Sale of HFCL Limited s Thermal Weapon Sights ( TWS ) business to...
Oil & Natural Gas Corporation Limited
Oil & Natural Gas Corporation Limited has informed the Exchange about Corrigendum in respect of Announcement Appointment of Director (Finance)...
HFCL Limited
HFCL Limited has informed the Exchange about Sale of up to 80% of the paid-up share capital of Raddef Private...
Amit Spinning Industries Limited
Amit Spinning Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. |SUBJECT:...
Akums Drugs and Pharmaceuticals Limited
Intimation of Schedule of the Investor/Analysts Meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates

Average Rating